⌘K

Home/Filings/4/0001209191-16-093705

4//SEC Filing

BioAmber Inc. 4

Accession 0001209191-16-093705

CIK 0001534287operating

View on SEC.gov Company Profile

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 11:04 AM ET

Size

5.7 KB

Accession

0001209191-16-093705

Insider Transaction Report

Form 4

Period: 2016-01-26

BioAmber Inc.BIOA

Hartmann Michael A.

Executive Vice President

Transactions

Award
Stock Option (right to buy)
2016-01-26+40,000→ 40,000 total
Exercise: $5.00Exp: 2026-01-26→ Common Stock (40,000 underlying)

Footnotes (2)

[F1]The exercise price represents a premium of $0.86 per share over grant date closing market price of BioAmber Inc. common stock on the New York Stock Exchange of $4.14 per share
[F2]These options will vest as follows: 25% will vest on 01/26/2017; the remaining 75% will vest on a monthly basis over the three (3) following years.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

BioAmber Inc.

CIK 0001534287

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001534287

Filing Metadata

Form type: 4
Filed: Jan 26, 7:00 PM ET
Accepted: Jan 27, 11:04 AM ET
Size: 5.7 KB

View on SEC.gov